News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
125 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32753)
Month
January (2936)
February (2969)
March (2710)
April (2907)
May (3626)
June (2409)
July (2088)
August (2589)
September (2381)
October (3064)
November (3190)
December (1884)
Day
2 (21)
3 (149)
4 (290)
5 (296)
6 (241)
7 (145)
10 (297)
11 (166)
12 (61)
13 (229)
14 (184)
17 (126)
18 (144)
19 (137)
20 (141)
21 (143)
24 (150)
25 (65)
26 (125)
27 (69)
28 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Opinion
Budget Cuts Are Hobbling American Innovation
The record-setting government shutdown was just the latest blow to the U.S. biopharma industry. When science funding becomes a casualty of political gridlock, we lose valuable talent, erode public trust and jeopardize our position as a global leader in innovation.
November 26, 2025
·
4 min read
·
Jennifer Perusini
Approvals
AstraZeneca Notches Another Indication for Imfinzi, Pushing PD-L1 Blocker Into Stomach Cancer
Imfinzi is the first immunotherapy approved for perioperative use to treat gastric and gastroesophageal junction cancers.
November 26, 2025
·
2 min read
·
Tristan Manalac
Approvals
Otsuka Secures IgAN Win as FDA Approves First Anti-APRIL Antibody
Analysts at Guggenheim Partners expect Voyxact to see “broad commercial uptake” given its relatively broad label compared with previous accelerated approvals for IgA nephropathy.
November 26, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Novo’s GLP-1s Highlight List as CMS Unveils Final Prices For Second Cycle of Drug Negotiations
The discounts should be compared against the drugs’ “ultimate net price” rather than their indicated list price to gauge the true impact of the negotiations, BMO Capital Markets analysts said.
November 26, 2025
·
2 min read
·
Tristan Manalac
Insights
Are Animals Out? How NAMs Are Changing the Rules of the Game
A coordinated national effort is emerging to bring alternatives to animal testing into routine preclinical use, backed by a fresh FDA roadmap and a global coalition of scientific and industry partners.
November 26, 2025
·
7 min read
·
BioSpace Insights
Press Releases
Kraig Biocraft Laboratories Launches Significant Hiring Initiative to Support Expanded Spider Silk Production Footprint in Southeast Asia
November 26, 2025
·
3 min read
Press Releases
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
November 26, 2025
·
1 min read
Press Releases
Amphista Therapeutics announces new AMX-883 data to be presented at the ASH Annual Meeting and Exposition and provides a business progress update
November 26, 2025
·
6 min read
Press Releases
Nurix Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
·
2 min read
Press Releases
Upstream Bio to Participate in Upcoming December 2025 Investor Conferences
November 26, 2025
·
1 min read
1 of 13
Next